Swift Medical builds AI-driven digital wound care tools and an imaging app used to standardize assessment, documentation, and remote care across the continuum of care. Core product offerings highlighted in the announcement include SmartTissue™, AutoDepth™ and HealingIndex™, which aim to improve wound evaluations, reduce treatment variability and identify risk more accurately. The company reports being the trusted wound care technology partner of more than 4,000 healthcare facilities in North America with over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, which underpin its clinical analytics and remote-care capabilities. Swift says its technology is associated with 37% faster wound healing and a 39% increase in measurement accuracy on darker skin tones in cited studies. Headquartered in Toronto, Swift operates across the U.S. and Canada and is pursuing broader commercialization and deployment of its AI tools. Swift Medical provides an AI-driven digital wound care platform that offers high-precision imaging, compliant documentation, clinical analytics, and remote care. The company serves more than 4,000 healthcare facilities across North America and has over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, supporting standardized and equitable wound care. Headquartered in Toronto, Swift is expanding operations across the U.S. and Canada. The company plans significant platform enhancements in 2024, including enhanced data security, improved interoperability, and enhanced device capabilities. The recent financing is intended to accelerate those technology improvements and expand the company’s reach. Swift Medical offers an AI-powered digital wound care platform that lets patients and clinicians capture high-precision wound images with a mobile phone, autonomously determine wound dimensions and clinical characteristics, enable virtual wound consultations, and provide real-time predictive insights. The technology is used by over 4,000 healthcare organizations across all 50 states and spans the full continuum of care. The company says it has grown 300% year-over-year in every new market it has entered over the past three years. Swift Medical positions itself as the dominant market player in digital wound management and emphasizes improving prevention, treatment, and management of wounds. With the new funding, the company plans to expand its market position and scale its platform across the care continuum in North America and continue growing its team. The stated mission is to prevent wounds before they occur and improve quality of care for every patient with a wound. Swift Medical offers an enterprise-grade, smartphone-ready Swift Skin and Wound software that delivers advanced wound visualization and touchless 3D measurement without touching the wound or requiring extra equipment. The platform captures images and measurements including wound depth, provides automatic risk scoring, schedules assessments, and supports claims submission to streamline clinical and administrative wound care workflows. Swift has been adopted by over 1,000 healthcare facilities managing more than 100,000 beds and reports helping heal over 10,000 patients a month. The company has partnerships with PointClickCare and Healogics and positions itself as a global market leader and enterprise solutions partner in digital wound care management. Management says the Series A funding will be used to expand reach and bring Swift’s solution to every bedside in hospitals and care facilities. Swift frames its mission around digitizing wound care management to augment clinician capabilities and address the global burden of chronic wounds.

Total raised

$59M

Funding rounds

4

Latest round

Equity

Latest activity

Mar 2024